Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Heron Therapeutics Inc (HRTX) vs Teradata Corporation Common Stock (TDC) Price & Performance

Heron Therapeutics IncTrade
Teradata Corporation Common StockTrade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs Teradata Corporation Common Stock — how do they compare? Heron Therapeutics Inc trades at $0.36 (market cap $74.18M), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: Teradata Corporation Common Stock is far larger — about 38.2× Heron Therapeutics Inc's market cap, and Teradata Corporation Common Stock is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 36 Days and Teradata Corporation Common Stock for 0 Days on average.

HRTXTDC
Market Cap
$74.18M$2.83B
Volume
1,857,4011,343,944
Sector
HealthTechnology
52-Week High
$1.49$37.88
52-Week Low
$0.27$20.71
Typical Hold Time
36 Days0 Days
Enterprise Value
$180.92M$2.52B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

HRTX trades at $0.3906, down 6.02% today, with a bullish technical signal from moving averages and oscillators. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates. Despite a high gross margin of 70.07%, it posted a net loss of -$20.20 million in 2025. Analyst consensus is strongly positive with 17 buy ratings. Recent news highlights earnings results and competitive comparisons.

The outlook remains speculative given persistent losses and negative ROE, but strong analyst support and improving cash flow trends offer potential upside. Key risks include profitability challenges and revenue volatility. Investors should weigh the bullish sentiment against fundamental weaknesses.

Teradata Corporation Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HRTX
67% Buy33% Sell
Avg holding period · 36 Days
TDC
100% Buy0% Sell
Avg holding period · 0 Days

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

Read more on HRTX →

About Teradata Corporation Common Stock

Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.

Read more on TDC →